<div id="readability-page-1">Amgen Inc. (NASDAQ:AMGN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. Amgen Inc. (NASDAQ:AMGN) has outperformed the broader market this year, supported by strong financial results and steady clinical progress, even as investors keep an eye on upcoming patent expirations. The stock is up more than 27% since the start […]</div>

安進

<p>安進（Amgen Inc.，NASDAQ:AMGN）被評選為 2026 年 14 只最佳製藥股息股票之一。該公司展現了強勁的財務表現和持續的臨牀進展，儘管面臨即將到來的專利到期的擔憂，今年股票價值仍增長了 27%</p>

安進（AMGN）憑藉強勁的業績和管線動能推動 2025 年的股價上漲